Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 67 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 17,975 followers.

RT @TristanRutland7: 10/so, maybe Tumour Neoantigen Burden (TNB) may be a better biomarker in the future??? 11a/ Article below for discuss…

01 Jul 2021

Reply Repost Favourite

10/so, maybe Tumour Neoantigen Burden (TNB) may be a better biomarker in the future??? 11a/ Article below for discussion, plus…. https://t.co/tiyt8gOKpi

29 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.